跳至主要内容
临床试验/ACTRN12621001118897
ACTRN12621001118897尚未招募未知

Development of multiparametric MRI biomarkers for accurate and informative assessment of treatment outcome following prostate radiotherapy. The Auckland BiRT Sequential Imaging” project (SI-BiRT).

The University of Auckland0 个研究点目标入组 10 人开始时间: 2021年8月23日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
Male

入选标准

  • Signed, written and informed consent
  • Biopsy proven localised prostate cancer
  • >= 18 years of age
  • Willing and able to comply with all study requirements
  • Completed MRI safety screening and contrast agent safety screening

排除标准

  • Mentally impaired participants or participants for who obtaining informed consent would be difficult
  • Unable to undergo an MRI examination or has contraindications to MRI
  • Inadequate renal function for contrast administration (eGFR threshold according to protocol) at baseline imaging
  • Participants who are unable or unwilling to remain still in MRI for up to 60 minutes
  • Prior pelvic radiotherapy
  • Any prosthetic implants such as metallic hip prostheses that may cause artefacts in the imaging studies
  • Prescribed ADT

研究者

相似试验